CENTRAL TRUST Co - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
CENTRAL TRUST Co ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$822,521
+0.9%
8,075
-0.1%
0.02%
+4.3%
Q2 2023$815,556
+14.7%
8,082
+4.6%
0.02%
+9.5%
Q1 2023$710,884
+5.1%
7,727
+3.6%
0.02%0.0%
Q4 2022$676,499
+20.6%
7,457
+1.0%
0.02%
+10.5%
Q3 2022$561,000
-17.3%
7,381
-8.0%
0.02%
-13.6%
Q2 2022$678,000
-9.4%
8,025
-5.9%
0.02%
+4.8%
Q1 2022$748,000
+1.9%
8,525
+1.6%
0.02%0.0%
Q4 2021$734,000
+5.8%
8,389
-1.1%
0.02%
-16.0%
Q3 2021$694,000
-12.4%
8,483
-2.3%
0.02%
-13.8%
Q2 2021$792,000
+9.2%
8,683
+2.4%
0.03%
+3.6%
Q1 2021$725,000
-25.9%
8,483
-18.1%
0.03%
-30.0%
Q4 2020$978,000
+3.9%
10,357
-4.3%
0.04%
-7.0%
Q3 2020$941,000
-15.3%
10,818
-15.0%
0.04%
-23.2%
Q2 2020$1,111,000
+2.0%
12,722
-3.7%
0.06%
-16.4%
Q1 2020$1,089,000
-8.6%
13,208
+5.0%
0.07%
+9.8%
Q4 2019$1,192,000
+29.6%
12,585
+18.9%
0.06%
+17.3%
Q3 2019$920,000
+3.4%
10,588
+7.4%
0.05%
+2.0%
Q2 2019$890,000
-3.4%
9,860
+2.9%
0.05%
-7.3%
Q1 2019$921,000
+12.2%
9,580
+0.2%
0.06%0.0%
Q4 2018$821,000
-3.1%
9,560
-2.7%
0.06%
+12.2%
Q3 2018$847,000
+12.9%
9,830
-0.9%
0.05%
+2.1%
Q2 2018$750,000
-29.4%
9,922
-24.5%
0.05%
-28.4%
Q1 2018$1,062,000
+27.5%
13,144
+32.4%
0.07%
+31.4%
Q4 2017$833,000
-10.0%
9,930
-7.9%
0.05%
-15.0%
Q3 2017$926,000
+3.9%
10,782
+1.0%
0.06%
+1.7%
Q2 2017$891,000
-7.3%
10,679
-17.4%
0.06%
-7.8%
Q1 2017$961,000
+1.2%
12,932
-0.9%
0.06%
-1.5%
Q4 2016$950,000
-6.5%
13,045
+1.5%
0.06%
-12.2%
Q3 2016$1,016,000
-4.0%
12,857
+0.3%
0.07%
-6.3%
Q2 2016$1,058,000
+18.1%
12,819
+3.7%
0.08%
+11.3%
Q1 2016$896,000
+7.2%
12,367
+27.2%
0.07%
+2.9%
Q4 2015$836,000
-4.9%
9,719
+1.7%
0.07%
-9.2%
Q3 2015$879,000
-6.6%
9,558
-0.0%
0.08%
+2.7%
Q2 2015$941,000
-0.6%
9,562
-0.4%
0.07%
-2.6%
Q1 2015$947,000
+2.8%
9,604
-3.5%
0.08%
+1.3%
Q4 2014$921,000
-1.0%
9,948
+0.7%
0.08%
+1.4%
Q3 2014$930,000
-2.3%
9,879
-6.0%
0.07%
-1.3%
Q2 2014$952,000
+6.5%
10,510
-0.1%
0.08%
+1.4%
Q1 2014$894,000
-1.0%
10,516
-6.4%
0.07%
-2.6%
Q4 2013$903,000
+1.7%
11,235
-2.9%
0.08%
-5.0%
Q3 2013$888,000
+6.1%
11,569
-2.3%
0.08%
+1.3%
Q2 2013$837,00011,8440.08%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders